Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
life sciences
national blog main
national top stories
alnylam pharmaceuticals
harvard pilgrim health care
institute for clinical and economic review
new york blog main
akcea therapeutics
amy schulman
andreas klein
anna greka
barry greene
biopharma
biotech
car-t
caron jacobson
cigall kadoch
craig mello
dan ollendorf
deals
drugs
duchenne
europe blog main
europe top stories
european medicines agency
events
fda
foghorn therapeutics
gene therapy
goldfinch biopharma
hereditary transthyretin amyloidosis
ideas
inotersen
licensing
luxturna
m&a
michael sherman
What
gene
4
×
rna
4
×
medicine
fda
interference
therapy
alnylam
approval
approves
aren’t
betting
billion
biopharma
car
cells
cephalopod
creature
cures
cutting
day
deal
drug
duchenne
edge
edit
editing
ema
employ
europe
experiments
follows
genetic
harmful
help
historic
hits
hot
human
launch
make
Language
unset
Current search:
rna
×
gene
×
@wired.com
4 years ago
Squids' Gene-Editing Superpowers May Unlock Human Cures
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
